Anna Wald

Anna Wald

University of Washington

H-index: 101

North America-United States

About Anna Wald

Anna Wald, With an exceptional h-index of 101 and a recent h-index of 49 (since 2020), a distinguished researcher at University of Washington, specializes in the field of clinical virology, STD's, genital herpes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Treatment and prevention of herpes simplex virus type 1 in immunocompetent adolescents and adults

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19

Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine

Prior herpes simplex virus infection and the risk of herpes zoster

Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing

SARS-CoV-2 Omicron sub-variant Neutralization following a primary vaccine series of NVX-CoV2373 and BNT162b2 monovalent booster vaccine

Delayed mortality among solid organ transplant recipients hospitalized for COVID-19

Treponema pallidum periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cells

Anna Wald Information

University

Position

___

Citations(all)

39254

Citations(since 2020)

9900

Cited By

33788

hIndex(all)

101

hIndex(since 2020)

49

i10Index(all)

357

i10Index(since 2020)

245

Email

University Profile Page

University of Washington

Google Scholar

View Google Scholar Profile

Anna Wald Skills & Research Interests

clinical virology

STD's

genital herpes

Top articles of Anna Wald

Title

Journal

Author(s)

Publication Date

Treatment and prevention of herpes simplex virus type 1 in immunocompetent adolescents and adults

Retrieved Feb

Anna Wald

Christine Johnston

2021

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19

Nature Immunology

Emily S Ford

Koshlan Mayer-Blackwell

Lichen Jing

Kerry J Laing

Anton M Sholukh

...

2024/1

Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine

Oncology

Elrazi Awadelkarim Hamid Ali

Ibrahim Khamees

Awni Alshurafa

Hanaa Qasim

Mohammad Abdullah Abu-Tineh

...

2022/7/26

Prior herpes simplex virus infection and the risk of herpes zoster

The Journal of Infectious Diseases

Ruth Harbecke

Michael N Oxman

Stacy Selke

Mark E Ashbaugh

Kristine F Lan

...

2024/1/15

Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing

medRxiv

Katharine HD Crawford

Stacy Selke

Gregory Pepper

Erin Goecker

Aniela Sobel

...

2024

SARS-CoV-2 Omicron sub-variant Neutralization following a primary vaccine series of NVX-CoV2373 and BNT162b2 monovalent booster vaccine

Open Forum Infectious Diseases

Tara M Babu

Xiaoying Shen

R Scott McClelland

Zijun Wang

Stacy Selke

...

2024/1/3

Delayed mortality among solid organ transplant recipients hospitalized for COVID-19

Sarah Georgia

Julie Steinbrink

Barbara Alexander

Emily Blumberg

Brandy Haydel

...

2022/2/25

Treponema pallidum periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cells

bioRxiv

Tara B Reid

Charmie Godornes

Victoria L Campbell

Kerry J Laing

Lauren C Tantalo

...

2024

Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron

Viruses

Linhui Hao

Tien-Ying Hsiang

Ronit R Dalmat

Renee Ireton

Jennifer F Morton

...

2023/2/14

Clinical and demographic factors associated with COVID-19, severe COVID-19, and SARS-CoV-2 infection in adults: a secondary cross-protocol analysis of 4 randomized clinical trials

JAMA network open

Deborah A Theodore

Angela R Branche

Lily Zhang

Daniel S Graciaa

Madhu Choudhary

...

2023/7/3

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature medicine

Angela R Branche

Nadine G Rouphael

David J Diemert

Ann R Falsey

Cecilia Losada

...

2023/9

Rapid development of an integrated network infrastructure to conduct phase 3 COVID-19 vaccine trials

JAMA network open

Alfredo J Mena Lora

Jessica E Long

Yunda Huang

Lindsey R Baden

Hana M El Sahly

...

2023/1/3

Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials

Annals of Epidemiology

Tara M Babu

Anna Wald

Arjee J Restar

2023/9/1

Bivalent and monovalent SARS-CoV-2 variant vaccine boosters improve coverage of the known antigenic landscape: results of the COVID-19 variant immunologic landscape (COVAIL) trial

Research Square

Angela Branche

Nadine Rouphael

David Diemert

Ann Falsey

Cecilia Losada

...

2023/5/5

2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults

Open Forum Infectious Diseases

Jennifer Whitaker

Paulina Rebolledo

Nadine Rouphael

Getahun Abate

Tara M Babu

...

2023/12

CD8+ T CELL CLONES FROM PRIOR SARS-CoV-2 INFECTION PREDOMINATE AFTER mRNA VACCINATION

Topics in Antiviral Medicine

E Ford

K Mayer-Blackwell

L Jing

A Sholukh

R St Germain

...

2023

Low prevalence of bacterial vaginosis in Kenyan adolescent girls and rapid incidence after first sex

American journal of obstetrics and gynecology

Alison C Roxby

Nelly R Mugo

Lynda M Oluoch

Kenneth Tapia

Melody Wang

...

2023/9/1

Adolescent girls and young women in Kenya demonstrate rapid STI incidence following first sex: data from a longitudinal cohort

Journal of Adolescent Health

Melody Wang

Kenneth Tapia

Lynda M Oluoch

Murugi Micheni

Stacy Selke

...

2023/4/1

Ancillary Care Obligations of Clinical Trial Investigators in the COVID-19 Pandemic

The American Journal of Bioethics

Tara M Babu

Anna Wald

2023/10/3

Genital Herpes Simplex Virus Type 2 Suppression With Valacyclovir Is Not Associated With Changes in Nugent Score or Absolute Abundance of Key Vaginal Bacteria

Open Forum Infectious Diseases

Tara M Babu

Sujatha Srinivasan

Amalia Magaret

Sean Proll

Helen Stankiewicz Karita

...

2023/3/1

See List of Professors in Anna Wald University(University of Washington)